DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Jindal Poly Films Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·9 Oct 2026, 12:26 pm

Jindal Poly Films

Jindal Poly Films Limited has informed stock exchanges that it has obtained a certificate under SEBI's Depositories and Participants Regulations, 2018. This regulatory compliance confirms that the company's shares are fully eligible for dematerialization and electronic settlement, ensuring smooth trading and settlement processes for investors.

This development is a routine administrative step that reinforces the company's adherence to market regulations. For investors, it ensures that the shares can be seamlessly transferred and settled in electronic form, maintaining the integrity of the transaction process.

Investors should monitor the company's future disclosures to ensure continued compliance with all regulatory requirements. This certificate is a standard procedural update and does not directly impact the company's operational performance or financial outlook.